Table 3. Hospitalization, toxicity and need for supportive care during mobilization and ASCT in myeloma patients according to the mobilization arm.

	Arm A (CY+G-CSF), N=34	Arm B (G-CSF), N=35	P
Days in hospital during mobilization, median (range)	3 (1−5)	0 (0−2)	<0.001
Days in hospital during apheresis, median (range)	3 (1−11)	3 (1−5)	0.228
Fever during mobilization, N (%)	4 (12%)	1 (3%)	0.169
IV antibiotics during mobilization, days median (range)	0 (0−9)	0 (0−12)	0.800
Toxic deaths during mobilization	0	0
Neutropenic fever during ASCT, N (%)	28 (90)	18 (67)	0.049
Platelet infusions during ASCT, units (range)	4 (0−24)	8 (0−28)	0.516
Red cell infusions during ASCT, units, (range)	0 (0–6)	0 (0−10)	0.567
Toxic deaths during ASCT	0	0
Days in hospital during ASCT, median (range)	21 (14−72), N=31	19 (14−29), N=27	0.577

Abbreviations: ASCT=autologous stem cell transplantation; CY=cyclophosphamide.